NCT06489600

A Clinical Study to Assess the Safety, In-use Tolerability of Test Product in Healthy Adult Subjects With Dry and Sensitive Skin.

Open-Label, Interventional, Prospective, Safety, In-Use Tolerability Study of Test Product "No Rays, Thanks Mineral Sunscreen" in Healthy Adult Subjects With Dry and Sensitive Skin.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 27 (actual)
• Sponsor: NovoBliss Research Pvt Ltd · Academic / Other
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This is open-label, interventional, prospective, safety in-use tolerability study of test product "No Rays, Thanks Mineral Sunscreen" in healthy adult human subjects with dry and sensitive skin.

Detailed description

A total of 27 subjects with preferably equal number of males and non-pregnant /non-lactating females will be enrolled to ensure a total of 25 subjects complete the study. The potential subjects will be screened as per the inclusion \& exclusion criteria only after obtaining written informed consent from the subjects. Subjects will be pre-screened by the screening department of NovoBliss Research. Subjects will be called on the telephone by the recruiting department prior to the enrolment visit. Subjects will be told during screening (prior to enrolment) not to wear any facial make-up on the study visit day. The adult male and female subjects will be instructed to visit the facility as per the below visits. * Visit 01 (Day 01): Screening, Enrolment, Baseline Evaluation, on site product usage, Post usage evaluation at T15 mins. * Visit 02 (Day 15 ±2 Days): Evaluations, End of Study

Conditions

• Dry Skin
• Sensitive Skin

Interventions

Type	Name	Description
OTHER	No Rays, Thanks Mineral sunscreen	Wash your face with standard facewash and apply a pea size amount on the face in the morning. Dosage form: semi-solid frequency: Once in a day Route of Administration: Topical

Timeline

• Start date: 2024-12-19
• Primary completion: 2025-01-04
• Completion: 2025-01-04
• First posted: 2024-07-08
• Last updated: 2025-03-03

Locations

1 site across 1 country: India